Published on 18/11/2025

Using Standards to Accelerate Submission, Review and Data Reuse

In the evolving landscape of clinical research, organizations are increasingly adopting standards that optimize data management processes. The integration of data standards such as CDISC’s SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) supports clinical trials, facilitating regulatory submissions in regions such as the US, UK, and EU. This comprehensive guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals with a step-by-step tutorial on utilizing these standards to enhance submission efficiency, review timelines, and data reuse capability, especially relevant to at home clinical trials.

What are CDISC Standards?

The Clinical Data Interchange Standards Consortium (CDISC) is a global initiative that develops data standards to ensure efficient and quality data exchange between various stakeholders in clinical research. CDISC standards aim to create a uniform language for clinical trial data, which can be utilized across different systems and organizations.

Two prominent standards developed by CDISC are:

• SDTM (Study Data Tabulation Model): A standard for organizing clinical trial data, allowing for uniformity in the way data is submitted to regulatory bodies.
• ADaM (Analysis Data Model): Provides guidelines for the preparation of datasets intended for statistical analysis and reporting.

Importance of CDISC Standards in Clinical Trials

Implementing CDISC standards in clinical trials is critical for various reasons:

• Enhanced Quality: Standardization improves data quality and consistency, making it easier for stakeholders to analyze and validate information.
• Streamlined Process: With a consistent structure, data handling becomes more efficient, reducing errors and retraining efforts.
• Regulatory Compliance: Regulatory agencies like the FDA and EMA expect sponsors to submit data that comply with these standards, which can significantly reduce time to approval.

Step 1: Understanding Regulatory Requirements

Before integrating CDISC standards into your clinical trials, it is essential to comprehend the specific requirements laid out by regulatory agencies. In the US, the FDA has clear guidelines on electronic submissions and data standards adoption, detailed in its CDER Guidance for Industry, which emphasizes the importance of SDTM and ADaM for clinical trial data submissions. Similarly, the EMA and MHRA have their respective frameworks that inform the use of standardized data in clinical submissions.

For successful navigation of the approval process, professionals must ensure their submissions align with these guidelines. Here are a few considerations:

• Submission Format: Familiarize yourself with the preferred submission formats required by each regulatory agency, including any specific data elements outlined in FDA or EMA guidelines.
• Mandatory Standards: Understand which data standards are mandatory for submission in certain therapeutic areas, including for clinical trials for dental implants or SMA clinical trials.
• Use of Metadata: Review any metadata requirements that complement submission standards to further enhance data interpretability.

Step 2: Design Your Clinical Trial with Standards in Mind

Integrating CDISC standards should begin at the earliest stages of trial design. This entails planning data collection parameters in alignment with SDTM and ADaM structures. Here’s how:

1. Protocol Development: Ensure that your study protocol clearly outlines the intended data collection and analysis methods based on CDISC standards. This should include appropriate domains for collection.

2. Case Report Forms (CRFs): Design CRFs that capture data conforming to SDTM standards. This will facilitate easier data entry and minimize the need for extensive data cleaning post-entry.

3. Data Management Plans: Develop a comprehensive data management plan incorporating standardized workflows, monitoring strategies, and validation checks for data consistency and quality.

4. Align with Analysis Plans: Ensure that your statistical analysis plans are designed to utilize ADaM standards, clearly outlining data derivations and statistical methods.

Step 3: Data Collection and Entry

Once your trial is designed, it is essential to maintain strict adherence to the established data collection and entry protocols. Here are critical steps to ensure compliance:

1. Staff Training: Train your clinical research staff on the importance of data standards, ensuring they are knowledgeable of SDTM and ADaM requirements. This helps prevent data entry errors and reinforces the importance of quality.

2. EDC Systems: Implement Electronic Data Capture (EDC) systems that support CDISC standards. Many EDC solutions provide built-in capabilities to manage data collection per SDTM structures directly.

3. Continuous Monitoring: Establish real-time monitoring processes to assess data quality throughout the trial. Utilize tools that facilitate proactive identification and resolution of data discrepancies.

Step 4: Data Transformation and Validation

After data collection, the next step is data transformation to align the collected data with SDTM for submission:

1. Data Mapping: Map collected data to CDISC standards, ensuring that each dataset adheres to SDTM rules. This task typically involves coordination between data managers and biostatisticians.

2. Validation Checks: Conduct both manual and automated validation checks on the transformed datasets to confirm compliance with both SDTM and ADaM. Verification should include assessments of missing data, inconsistencies, and logical errors.

3. Documentation: Maintain comprehensive documentation of the data transformation process. This is critical for audit trails and regulatory submission, asserting transparency in data handling processes.

Step 5: Submission of Study Data

Once the data transformation and validation processes are complete, the final step involves submitting the study data:

1. Submission Format: Prepare the datasets according to the regulatory agency’s submission requirements. This may include specifics on file formats (e.g., SAS, XML) and naming conventions.

2. Regulatory Authorities Submission: Ensure that your final datasets, along with accompanying documents, are submitted to the relevant regulatory authorities (e.g., FDA, EMA). You must follow guidelines for electronic submissions to ensure compliance.

3. Submission Tracking: After submitting the data, maintain tracking processes to monitor the status of your submission and be prepared to respond to request queries or clarifications from the regulatory body.

Step 6: Data Reuse for Future Research

One significant advantage of utilizing CDISC standards is the ability to reuse data for future research initiatives. By ensuring that data is collected and stored according to standardized models, researchers can facilitate:

1. Quick Access: Other teams within your organization or external partners can easily access the standardized datasets for comparative studies or additional analyses without extensive restructuring.

2. Increased Collaboration: Data sharing among different research entities becomes easier when a common standard is adopted. This facilitates collaborative research efforts across various studies, such as the lecanemab clinical trial or recently initiated at home clinical trials.

3. Enhanced Publications: The utilization of standardized datasets enables researchers to more easily publish findings, contributing to the body of literature with robust data analyses.

Conclusion

Implementing CDISC standards such as SDTM and ADaM in clinical trials offers a tactile pathway to enhance submission processes, accelerate review timelines, and promote data reuse across various research initiatives. Adopting a structured approach, as detailed in this guide, facilitates successful navigation of regulatory environments in the US, UK, and EU while fostering high-quality clinical research that aligns with contemporary scientific advancements.

As the clinical research landscape continues to evolve with the integration of standards, embracing these methodologies will not only enhance operational efficiencies but also position your organization as a leader in quality data management practices.